Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 70309-70310 [2013-28113]
Download as PDF
<![CDATA[
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 227 / Monday, November 25, 2013 / Notices
comments relating to the contemplated
exclusive license should be directed to:
Sabarni K. Chatterjee, Ph.D., M.B.A.
Licensing and Patenting Manager,
Cancer Branch, Office of Technology
Transfer, National Institutes of Health,
6011 Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; Telephone:
(301) 435–5587; Facsimile: (301) 435–
4013; Email: chatterjeesa@od.nih.gov.
SUPPLEMENTARY INFORMATION: The
technology describes the use of chitosan
depots with appropriate antigens and/or
cytokines for generating an immune
response in a subject. Such depots are
made by mixing one or more antigens
and/or cytokines with chitosan or a
chitosan derivative. Similar
compositions are described wherein
chitosan or a derivative forms a microor nanoparticle, which have resulted in
a more immunogenic presentation of
antigen compared to antigen in solution.
Using a representative antigen, the
inventors showed that mice vaccinated
with the subject depots had increased
humoral and cellular immune responses
compared to mice vaccinated with
antigen alone. Furthermore,
comparative mouse studies showed the
antigen-specific immune response
generated with chitosan depots of this
invention to be equipotent to
incomplete Freund’s adjuvant (IFA) and
superior to aluminum hydroxide, a
widely used adjuvant for licensed and
routinely administered vaccines. Thus,
this technology improves upon
commonly used adjuvant technology
and is widely applicable.
This technology is the first to show
that subcutaneous administrations of
chitosan and an appropriate antigen,
with no other component, can be used
for enhancing immune responses. In
additional studies, the inventors
showed that chitosan is able to maintain
a depot of recombinant cytokine. A
single subcutaneous injection of
chitosan-cytokine outperforms daily
injections of recombinant cytokine in
both the expansion of draining lymph
nodes and in the antigen presenting
ability of lymph node cells. This
technology is the first to show that
chitosan can maintain a depot of
cytokine which results in a significant
enhancement of the functional effects of
a cytokine. This technology can be used
for vaccines and immunotherapies
against various infectious agents and
cancer.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless
within thirty (30) days from the date of
VerDate Mar<15>2010
17:53 Nov 22, 2013
Jkt 232001
this published notice, the NIH receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: November 18, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2013–28119 Filed 11–22–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: December 2, 2013.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6902, peter.zelazowski@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
70309
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; MicroRNAs and
Trophoblasts.
Date: December 2, 2013.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–451–3415, duperes@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Assessing Placental
Development and Function SBIR.
Date: December 3, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: David Weinberg, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–7510, 301–435–6973,
David.Weinberg@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Pediatric Orthotics
SBIR.
Date: December 4, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: David Weinberg, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–7510, 301–435–6973,
David.Weinberg@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: December 4, 2013.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\25NON1.SGM
25NON1
sroberts on DSK5SPTVN1PROD with NOTICES
70310
Federal Register / Vol. 78, No. 227 / Monday, November 25, 2013 / Notices
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive Blvd.,
Room 5B01, Bethesda, MD 20892, 301–435–
6911, hopmannm@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: December 4, 2013.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive Blvd.,
Room 5B01, Bethesda, MD 20892 301–435–
6902, peter.zelazowski@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: December 5, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive Blvd.,
Room 5B01, Bethesda, MD 20892, 301–435–
6911, hopmannm@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Fragile X Syndrome.
Date: December 9, 2013.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5b01, Bethesda, MD
20892, 301–451–3415, duperes@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Biobehavioral and Behavioral
Sciences Subcommittee.
VerDate Mar<15>2010
17:53 Nov 22, 2013
Jkt 232001
Date: December 12–13, 2013.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Washington, 1515
Rhode Island Avenue NW., Washington, DC
20005.
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive Blvd.,
Room 5b01, Bethesda, MD 20892, 301–435–
6911, hopmannm@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Strategies To
Prevent Mother/Child Transmission of HIV–
RFA.
Date: December 18–19, 2013
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree by Hilton Hotel, 1515
Rhode Island Avenue NW., Washington, DC
20005.
Contact Person: Carla T. Walls, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Child Health
and Human Development, NIH, 6100
Executive Blvd., Room 5b01, Bethesda, MD
20892, 301–435–6898, wallsc@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; T32 Institutional
Training Grant Award.
Date: January 9–10, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sherry L. Dupere, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–451–3415, duperes@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 19, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–28113 Filed 11–22–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Exercise and
AD.
Date: December 23, 2013.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Rebecca J. Ferrell, Ph.D.,
Scientific Review Officer, National Institute
on Aging, Gateway Building, Rm. 2C212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703, ferrellrj@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; MDD and
CVD.
Date: January 3, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Rebecca J. Ferrell, Ph.D.,
Scientific Review Officer, National Institute
on Aging, Gateway Building, Rm. 2c212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–402–7703, ferrellrj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS).
Dated: November 19, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–28116 Filed 11–22–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 78, Number 227 (Monday, November 25, 2013)]
[Notices]
[Pages 70309-70310]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28113]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: December 2, 2013.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D., Scientific Review
Officer, Division of Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6902,
peter.zelazowski@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; MicroRNAs and Trophoblasts.
Date: December 2, 2013.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D., Chief, Scientific
Review Branch, Scientific Review Branch, National Institute of Child
Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01,
Bethesda, MD 20892, 301-451-3415, duperes@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Assessing Placental Development
and Function SBIR.
Date: December 3, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: David Weinberg, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892-7510, 301-435-6973,
David.Weinberg@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Pediatric Orthotics SBIR.
Date: December 4, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: David Weinberg, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892-7510, 301-435-6973,
David.Weinberg@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: December 4, 2013.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 70310]]
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6911,
hopmannm@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: December 4, 2013.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892 301-435-6902,
peter.zelazowski@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: December 5, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6911,
hopmannm@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Fragile X Syndrome.
Date: December 9, 2013.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D., Chief, Scientific
Review Branch, Scientific Review Branch, National Institute of Child
Health and Human Development, NIH, 6100 Executive Blvd., Room 5b01,
Bethesda, MD 20892, 301-451-3415, duperes@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Biobehavioral and Behavioral
Sciences Subcommittee.
Date: December 12-13, 2013.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Washington, 1515 Rhode Island Avenue
NW., Washington, DC 20005.
Contact Person: Marita R. Hopmann, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5b01, Bethesda, MD 20892, 301-435-6911,
hopmannm@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Strategies To Prevent Mother/
Child Transmission of HIV-RFA.
Date: December 18-19, 2013
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: DoubleTree by Hilton Hotel, 1515 Rhode Island Avenue NW.,
Washington, DC 20005.
Contact Person: Carla T. Walls, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Child
Health and Human Development, NIH, 6100 Executive Blvd., Room 5b01,
Bethesda, MD 20892, 301-435-6898, wallsc@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; T32 Institutional Training Grant
Award.
Date: January 9-10, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: DoubleTree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sherry L. Dupere, Ph.D., Chief, Scientific
Review Branch, Scientific Review Branch, National Institute of Child
Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01,
Bethesda, MD 20892, 301-451-3415, duperes@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 19, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-28113 Filed 11-22-13; 8:45 am]
BILLING CODE 4140-01-P
